Oryzon Genomics S.A. (BME:ORY)

Oryzon Genomics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 29, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	269	91	115	133	142	210
Market Cap Growth	138.13%	-21.18%	-13.63%	-6.58%	-32.20%	66.16%
Enterprise Value	256	99	121	129	124	180
Last Close Price	3.41	1.40	1.89	2.48	2.70	3.50
Forward PE	-	106.87	-	-	-	-
PS Ratio	35.99	12.31	8.10	8.48	13.42	22.07
PB Ratio	2.35	1.04	1.41	1.83	2.00	2.77
P/TBV Ratio	2.36	1.04	1.41	1.85	2.02	2.78
EV/Sales Ratio	34.25	13.40	8.53	8.19	11.66	18.92
Debt / Equity Ratio	0.16	0.19	0.22	0.31	0.25	0.18
Asset Turnover	0.06	0.07	0.14	0.16	0.11	0.11
Inventory Turnover	42.35	67.11	30.80	8.17	3.55	1.74
Quick Ratio	2.62	0.74	0.87	1.34	3.75	5.47
Current Ratio	2.62	0.75	0.87	1.34	3.76	5.51
Return on Equity (ROE)	-4.20%	-4.34%	-4.35%	-5.88%	-6.37%	-4.96%
Return on Assets (ROA)	-2.52%	-2.61%	-2.71%	-3.45%	-4.63%	-3.08%
Return on Capital (ROIC)	-2.65%	-2.77%	-2.92%	-3.74%	-4.92%	-3.27%
Earnings Yield	-1.57%	-4.05%	-2.92%	-3.18%	-3.29%	-1.62%
FCF Yield	-	-6.28%	-0.50%	-1.44%	-2.67%	-2.37%
Buyback Yield / Dilution	-23.15%	-6.35%	-10.10%	-4.80%	-	-15.99%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.